OOIR: Observatory of International Research

Papers

(The H4-Index of Dermatology and Therapy is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Machine Learning in Dermatology: Current Applications, Opportunities, and Limitations	127
Spesolimab, an Anti-Interleukin-36 Receptor Antibody, in Patients with Palmoplantar Pustulosis: Results of a Phase IIa, Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot Study	55
Selectivity Profile of the Tyrosine Kinase 2 Inhibitor Deucravacitinib Compared with Janus Kinase 1/2/3 Inhibitors	55
Long-term Safety of Oral Systemic Therapies for Psoriasis: A Comprehensive Review of the Literature	47
Menopause and the Skin: Old Favorites and New Innovations in Cosmeceuticals for Estrogen-Deficient Skin	46
The Pathogenic Role of Demodex Mites in Rosacea: A Potential Therapeutic Target Already in Erythematotelangiectatic Rosacea?	43
Comparative Efficacy and Relative Ranking of Biologics and Oral Therapies for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis	42
Gut–Brain–Skin Axis in Psoriasis: A Review	40
Topical Probiotics in Dermatological Therapy and Skincare: A Concise Review	39
Efficacy and Safety of Oral Minoxidil 5 mg Once Daily in the Treatment of Male Patients with Androgenetic Alopecia: An Open-Label and Global Photographic Assessment	39
Rosacea and the Microbiome: A Systematic Review	38
Unmet Medical Needs in the Treatment and Management of Generalized Pustular Psoriasis Flares: Evidence from a Survey of Corrona Registry Dermatologists	37
A Review on the Safety of Using JAK Inhibitors in Dermatology: Clinical and Laboratory Monitoring	36
Rosacea Treatment: Review and Update	36
Can COVID-19 Increase the Risk of Herpes Zoster? A Narrative Review	36
Sonidegib: Safety and Efficacy in Treatment of Advanced Basal Cell Carcinoma	34
A Review of Current Keloid Management: Mainstay Monotherapies and Emerging Approaches	34
Artificial Intelligence in Dermatology: Challenges and Perspectives	34
The Economic and Psychosocial Comorbidity Burden Among Adults with Moderate-to-Severe Atopic Dermatitis in Europe: Analysis of a Cross-Sectional Survey	33
Pustular Psoriasis: A Narrative Review of Recent Developments in Pathophysiology and Therapeutic Options	33
Patient Perspectives of the Social, Emotional and Functional Impact of Alopecia Areata: A Systematic Literature Review	33
Treat-to-Target Approach for the Management of Patients with Moderate-to-Severe Plaque Psoriasis: Consensus Recommendations	33
Urea in Dermatology: A Review of its Emollient, Moisturizing, Keratolytic, Skin Barrier Enhancing and Antimicrobial Properties	30
Psoriasis Prevalence and Severity by Expert Elicitation	29
Interleukin-17 and Interleukin-23: A Narrative Review of Mechanisms of Action in Psoriasis and Associated Comorbidities	29

Vitiligo, From Physiopathology to Emerging Treatments: A Review	28
Deucravacitinib in Moderate to Severe Psoriasis: Clinical and Quality-of-Life Outcomes in a Phase 2 Trial	28
Updated Treatment for Acne: Targeted Therapy Based on Pathogenesis	27
The Japanese Experience with Basic Fibroblast Growth Factor in Cutaneous Wound Management and Scar Prevention: A Systematic Review of Clinical and Biological Aspects	27
Risankizumab for the Treatment of Moderate-to-Severe Psoriasis: Real-Life Multicenter Experience from the Czech Republic	27
Ixekizumab and Ustekinumab Efficacy in Nail Psoriasis in Patients with Moderate-to-Severe Psoriasis: 52-Week Results from a Phase 3, Head-to-Head Study (IXORA-S)	27